Skip to main content
SpringerLink
Log in

Expression of the estrogen receptor gene in developing and adult human breast

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Although studies of the estrogen receptor gene abound in rodent models and breast cancer cell lines, little is known about expression of this gene in normal human breast. Information regarding the physiology of this gene's expression is important if we are to elucidate abnormalities of the gene that may be involved in breast carcinogenesis. We evaluated levels of mRNA expression of the estrogen receptor (ER) gene and its protein product in a set of 89 breasts from clinically normal female infants, children, adolescents, and adult premenopausal and post-menopausal women. mRNA expression of the gene varied with the hormonal status. Relatively higher levels of gene transcripts were found in breasts of peri-menarchal girls, women in the luteal phase of the menstrual cycle, and in those with fibrocystic change. Higher levels were also occasionally found in breasts of infants and in most pre-adolescent children. Lower levels were seen in breasts of women in the follicular phase of the menstrual cycle, during pregnancy, and after menopause. Nuclear protein staining was common in breasts of normal children and peri-menarchal adolescents, and in post-menopausal atrophic breasts. Nuclear ER protein was infrequently detected in reproductive aged women's breasts, but was more often seen in follicular than in luteal menstrual phase or pregnant breast. ER protein was more frequently seen in post-menopausal than in pre-menopausal breasts with fibrocystic change. The results fit a model in which circulating levels of estrogen are inversely related to levels of mRNA transcribed from the estrogen receptor gene in normal physiologic states. Abnormally high levels of gene transcription may occur in some cases of fibrocystic change.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Drife JO: Breast development in puberty. Ann NY Acad Sci 464: 58–65, 1986

    PubMed  Google Scholar 

  2. Muldoon TG: Steroid hormone receptor regulation by various hormonal factors during mammary development and growth in the normal mouse. Ann NY Acad Sci 464: 17–36, 1986

    PubMed  Google Scholar 

  3. Marshal E: Epidemiology. Search for a killer focus shifts from fat to hormones (news). Science 259: 618–221, 1993

    PubMed  Google Scholar 

  4. Hulka BS, Liu ET, Lininger RA: Steroid hormones and risk of breast cancer. Cancer 74: 1111–1124, 1994

    PubMed  Google Scholar 

  5. O'Malley BW, Means AR: Female steroid hormones and target cell nuclei. Science 183: 610–620, 1974

    PubMed  Google Scholar 

  6. Horwitz KB, McGuire WL: Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185–8191, 1978

    PubMed  Google Scholar 

  7. Carson-Jurica MA, Schrader WT, O'Malley BW: Steroid receptor family: structure and functions. Endocrine Reviews 11: 201–220, 1980

    Google Scholar 

  8. Katzenellenbogen BS: Dynamics of steroid hormone receptor action. Ann Rev Physiol 42: 17–35, 1980

    Google Scholar 

  9. Ringold GM: Steroid hormone regulation of gene expression. Ann Rev Pharmacol Toxicol 25: 529–566, 1985

    Google Scholar 

  10. Yamamoto K: Steroid receptor regulated transcription of specific genes and gene networks. Ann Rev Genet 19: 209–252, 1985

    PubMed  Google Scholar 

  11. King RJB: Oestrogen-receptors: an overview of recent advances in their structure and function. Proc Royal Soc Edinburgh 95B: 133–144, 1989

    Google Scholar 

  12. McCarty KS Jr: Proliferative stimuli in the normal breast: estrogens of progestins? Human Pathol 20: 1137–1138, 1989

    Google Scholar 

  13. Peterson OW, Hoyer PE, van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748–5751, 1987

    PubMed  Google Scholar 

  14. Markopoulos C, Berger U, Wilson P, Gazet J-C, Coombes RC: Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J 296: 1349–1351, 1988

    Google Scholar 

  15. Carpenter S, Georgiade G, McCarty KS Sr, McCarty KS Jr: Immunohistochemical expression of oestrogen receptor in normal breast tissue. Proc Royal Soc Edinburgh 95B: 59–66, 1989

    Google Scholar 

  16. Jacquemier JD, Hassoun J, Torrente M, Martin PM: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109–117, 1990

    PubMed  Google Scholar 

  17. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet J-C, Nolan C, Coombes RC: Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817–1822, 1991

    PubMed  Google Scholar 

  18. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Patten CS: Oral contraceptive (OCP) use increases proliferative and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48: 206–210, 1991

    Google Scholar 

  19. Battersby S, Robertson BJ, Anderson TJ, King RJB, McPherson K: Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 65: 601–607, 1992

    PubMed  Google Scholar 

  20. Feherty P, Farver-Brown G, Kellie AE: Oestradiol receptors in carcinoma and benign disease of the breast: anin vitro assay. Br J Cancer 25: 697–710, 1971

    PubMed  Google Scholar 

  21. Rosen PP, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Miké V, Fracchia A, Schwartz MK: Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res 35: 3187–3194, 1975

    PubMed  Google Scholar 

  22. Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P: Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 9: 1251–1255, 1978

    PubMed  Google Scholar 

  23. Allegra JC, Lippman ME, Green L, Barlock A, Simon R, Thompson EB, Huff KK, Griffin W: Estrogen receptor values in patients with benign breast disease. Cancer 44: 228–231, 1979

    PubMed  Google Scholar 

  24. Giani C, D'Amore E, Delarue JC, Mouriesse H, May-Levin F, Sancho-Garnier H, Breccia M, Contesso G: Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Int J Cancer 37: 7–10, 1986

    PubMed  Google Scholar 

  25. Brentani MM, Franco EL, Oshima CTF, Pacheco MM: Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach. Int J Cancer 38: 637–642, 1986

    PubMed  Google Scholar 

  26. Balakrishnan A, Yang J, Beattie CW, Das Gupta TK, Nandi S: Estrogen receptor in dissociated and cultured human breast fibroadenoma epithelial cells. Cancer Letters 34: 233–242, 1987

    PubMed  Google Scholar 

  27. Longacre TA, Bartow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382–393, 1986

    PubMed  Google Scholar 

  28. Vogel PM, Georgiade NG, Fetter BJ, Vogel FS, McCarty KS Jr: The correlation of histological changes in the human breast with the menstrual cycle. Am J Pathol 104: 23–34, 1981

    PubMed  Google Scholar 

  29. Cancer Committee of the College of American Pathologists. Is fibrocystic disease of the breast precancerous? A consensus meeting, October 3 to October 5, 1981: New York. Arch Pathol Lab Med 110: 171–173, 1986

    Google Scholar 

  30. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299, 1979

    PubMed  Google Scholar 

  31. Lehrach H, Diamond D, Wozney JM, Boedtker J: RNA molecular weight determination by gel electrophoresis under denaturing conditions; a critical re-examination. Biochemistry 16: 4743–4751, 1977

    PubMed  Google Scholar 

  32. Bonini JA, Hofmann C: A rapid, accurate, non-radioactive method for quantitating RNA on agarose gels. Biotechniques 11: 708–709, 1991

    PubMed  Google Scholar 

  33. Correa-Rotter R, Mariash CN, Rosenberg ME: Loading and transfer control for northern hybridization. Biotechniques 12: 154–158, 1992

    PubMed  Google Scholar 

  34. Walter P, Green S, Greene G, Krust A, Bornert J-M, Jeltsch J-M, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci 82: 7889–7893, 1985

    PubMed  Google Scholar 

  35. Greene GL, Press MF: Structure and dynamics of the estrogen receptor. I. Steroid receptor structure (including monoclonal antibodies and new methods of determination). J Steroid Biochem 24: 1–7, 1986

    Google Scholar 

  36. Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Johnsen T, Aakvaag A, Hanson V: Autologous down-regulation of messenger ribonucleic acid and protein levels of estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology 124: 2577–2583, 1989

    PubMed  Google Scholar 

  37. Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM: Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313: 231–233, 1985

    PubMed  Google Scholar 

  38. Eidne KA, Flanagan CA, Harris NS, Millar RP: Gonadotropin releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 64: 425–432, 1987

    PubMed  Google Scholar 

  39. Fekete M, Bajusz S, Groot K, Csernus V, Schally AV: Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes. Endocrinology 946–955, 1989

  40. Keri G, Balogh A, Szoke B, Teplan I, Csuka O: Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line. Tumor Biol 12: 61–67, 1991

    Google Scholar 

  41. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P: Functional domains of the human estrogen receptor. Cell 51: 941–951, 1987

    PubMed  Google Scholar 

  42. Kumar V, Chambon P: The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145–156, 1988

    PubMed  Google Scholar 

  43. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385–3388, 1988

    PubMed  Google Scholar 

  44. Wahli W, Martinez E: Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J 5: 2243–2249, 1991

    PubMed  Google Scholar 

  45. van der Burg B, van Selm-Miltenburg AJP, de Laat SW, van Zoelen EJJ: Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 64: 223–228, 1989

    PubMed  Google Scholar 

  46. Aronica SM, Katzenellenbogen BS: Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′, 5′-monophosphate, and insulin-like growth factor I and suppression by anti-estrogens and protein kinase inhibitors. Endocrinology 128: 2045–2052, 1991

    PubMed  Google Scholar 

  47. Mishell DR Jr, Davajan V: The menstrual cycle.In: Reproductive Endocrinology, Infertility and Contraception. Philadelphia, F.A. Davis Company, 1979, pp 67–89

    Google Scholar 

  48. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the ‘resting’ human breast. Br J Cancer 44: 177–181, 1981

    PubMed  Google Scholar 

  49. Meyer JS: Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labelling with tritiated thymidine: effects of menstrual phase, age and oral contraceptive hormones. Human Pathol 8: 67–81, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of New Mexico, 87131, Albuquerque, NM, USA

    Marie T. Boyd, Richard H. Hildebrandt & Sue A. Bartow

Authors
  1. Marie T. Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard H. Hildebrandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sue A. Bartow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boyd, M.T., Hildebrandt, R.H. & Bartow, S.A. Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res Tr 37, 243–251 (1996). https://doi.org/10.1007/BF01806506

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806506

Key words

Search

Navigation